One-year nonrelapse mortality
. | Nonablative . | Ablative . | P . |
|---|---|---|---|
| Causes of death, n | |||
| Infection/GVHD | 10 | 14 | |
| SOS | 0 | 5 | |
| Acute lung injury | 0 | 2 | |
| CNS | 2 | 1 | |
| Total, n | 12 | 22 | .04 |
| Cumulative incidence, % | 16 | 30 |
. | Nonablative . | Ablative . | P . |
|---|---|---|---|
| Causes of death, n | |||
| Infection/GVHD | 10 | 14 | |
| SOS | 0 | 5 | |
| Acute lung injury | 0 | 2 | |
| CNS | 2 | 1 | |
| Total, n | 12 | 22 | .04 |
| Cumulative incidence, % | 16 | 30 |
GVHD indicates graft-versus-host-disease; SOS, sinusoidal obstruction syndrome; CNS, central nervous system toxicity.